Merck
MRK
#53
Rank
โ‚น27.962 T
Marketcap
โ‚น11,322
Share price
-1.42%
Change (1 day)
62.04%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): โ‚น303.66

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น338.30. In 2025 the company made an earnings per share (EPS) of โ‚น693.03 an increase over its 2024 EPS that were of โ‚น642.80.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น303.66-56.18%
2025โ‚น693.037.81%
2024โ‚น642.804308.46%
2023โ‚น14.58-97.32%
2022โ‚น544.9210.92%
2021โ‚น491.2784.68%
2020โ‚น266.02-27.2%
2019โ‚น365.4063.44%
2018โ‚น223.56151.11%
2017โ‚น89.03-54.58%
2016โ‚น195.9930.21%
2015โ‚น150.52-61.99%
2014โ‚น395.97180.51%
2013โ‚น141.16-31.82%
2012โ‚น207.046.62%
2011โ‚น194.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น830.83 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น667.60 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น124.58-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น343.18 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,684 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,377 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น243.42-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น338.56 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น369.59 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น130.29-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel